Memorandum from NZSG

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website.